{"anticipatedPostingDate":"2027-05","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"From randomization up to 30 days after last dose of study treatment or disease progression or initiation of subsequent therapy, whichever occurs first (up to 3 years)","title":"Percentage of Participants Who Achieved Durable (Greater Than or Equal to [>=] 12 Months) MRD Negative Status (10^-5)","type":"SECONDARY"}